Clinical Trial Update: Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp [Phase 3]

View source ↗

Summary

Phase 3 study of Levulan with blue light for actinic keratosis on the face or scalp was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• Levulan with Blue Light (5-aminolevulinic acid)

Snippet

Sponsor: DUSA Pharmaceuticals, Inc. | Conditions: Actinic Keratosis | Phase 3 | Status: WITHDRAWN